**Question:** All of the following are true about multiple myeloma except?

A. Multiple myeloma is a plasma cell disorder characterized by the clonal proliferation of plasma cells in the bone marrow.
B. It is a rare disease, affecting less than 1% of all cancer cases.
C. The primary treatment goal is to achieve a complete remission followed by maintenance therapy.
D. The disease is always associated with a high-risk genetic profile.

**Correct Answer:** .

**Core Concept:**
Multiple myeloma is a plasma cell disorder characterized by the clonal proliferation of plasma cells in the bone marrow. These cells are responsible for producing monoclonal proteins, which can lead to various complications and clinical manifestations. The disease is more common in adults aged 60 years and older, with a male-to-female ratio of approximately 1:1.

**Why the Correct Answer is Right:**
Option D is incorrect because multiple myeloma can present with a wide range of genetic profiles, not necessarily being associated with a high-risk genetic profile. While some patients may have high-risk genetic abnormalities, others can present with more indolent or low-risk genetic profiles. The genetic landscape of multiple myeloma is complex and involves various chromosomal translocations, copy number alterations, and gene mutations.

**Why Each Wrong Option is Incorrect:**

A. This option is correct as multiple myeloma is a plasma cell disorder characterized by the clonal proliferation of plasma cells in the bone marrow. The disease is caused by the uncontrolled growth of malignant plasma cells, leading to the production of monoclonal proteins, which can cause complications like osteolytic lesions, renal impairment, and hypercalcemia.

B. Multiple myeloma is a relatively common hematological malignancy, affecting around 1% of all cancer cases. However, it is not as rare as stated in this option.

C. While achieving a complete remission and maintenance therapy are important treatment goals for multiple myeloma, the primary treatment goal is to prolong survival and improve quality of life by addressing symptoms and complications, rather than solely focusing on achieving a complete remission.

**Clinical Pearl:**
The genetic landscape of multiple myeloma is complex and involves various chromosomal translocations, copy number alterations, and gene mutations. This heterogeneity in genetic profiles contributes to the disease's clinical variability and treatment challenges. Understanding this complexity is essential for accurate diagnosis, treatment planning, and patient management.